Literature DB >> 9674084

Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.

A P Souka1, R J Snijders, A Novakov, W Soares, K H Nicolaides.   

Abstract

Increased fetal nuchal translucency thickness at 10-14 weeks of gestation is a common phenotypic expression of fetal chromosomal defects, structural abnormalities and genetic syndromes. This study reports on the prevalence of structural abnormalities and genetic syndromes in 4116 chromosomally normal pregnancies with increased fetal nuchal translucency thickness and reviews the relevant literature. In fetuses with increased nuchal translucency thickness, the prevalence of major cardiac defects, diaphragmatic hernia, exomphalos, body stalk anomaly and fetal akinesia deformation sequence is substantially higher than expected in the general population. In addition, there may be an association between increased nuchal translucency thickness and a wide range of rare skeletal dysplasias and genetic syndromes that are usually found in less than one in 10,000 pregnancies; however, the number of affected cases, both in the present and in previous series of fetuses with increased nuchal translucency thickness, is too small for definite conclusions to be drawn. The rates of miscarriage and perinatal death increase, whereas the rate of survival and the prevalence of live births with no obvious abnormalities decrease with increasing nuchal translucency thickness.

Entities:  

Mesh:

Year:  1998        PMID: 9674084     DOI: 10.1046/j.1469-0705.1998.11060391.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  18 in total

1.  Increased nuchal traslucency in normal karyotype fetuses.

Authors:  Roberta De Domenico; Marianna Faraci; Entela Hyseni; Fosca A F Di Prima; Oriana Valenti; Santo Monte; Elsa Giorgio; Eliana Renda
Journal:  J Prenat Med       Date:  2011-04

2.  Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study.

Authors:  Marie-Victoire Senat; Laurence Bussières; Sophie Couderc; Joelle Roume; Patrick Rozenberg; Jean Bouyer; Yves Ville
Journal:  Am J Obstet Gynecol       Date:  2007-01       Impact factor: 8.661

3.  Quadruple test parameters in art pregnancies.

Authors:  Nilgün Güdücü; Uzay Görmüş; Ebru İlhan Güner; Omer Güzel; Zehra Neşe Kavak
Journal:  Int J Clin Exp Med       Date:  2014-08-15

4.  Increased nuchal translucency and short femur length as possible early signs of osteogenesis imperfecta type III.

Authors:  Antonella Vimercati; Mariantonietta Panzarino; Ilaria Totaro; Annarosa Chincoli; Luigi Selvaggi
Journal:  J Prenat Med       Date:  2013-01

Review 5.  Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy.

Authors:  Laura Goetzl
Journal:  Clin Lab Med       Date:  2010-09       Impact factor: 1.935

6.  Prenatal diagnosis for paediatricians.

Authors:  Anne Summers
Journal:  Paediatr Child Health       Date:  2003-01       Impact factor: 2.253

7.  Role of MR imaging in prenatal diagnosis of pregnancies at risk for Joubert syndrome and related cerebellar disorders.

Authors:  S N Saleem; M S Zaki
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

8.  Performance of Common Down Syndrome Screening Methods Used in India with Construction of an Indian Normogram for Nuchal Translucency/Crown-Rump Length Measurements in 14,337 Subjects.

Authors:  Anita Kaul; Prathima Radhakrishnan
Journal:  J Obstet Gynaecol India       Date:  2019-01-17

9.  Increased nuchal translucency and pregnancy outcome.

Authors:  A Tahmasebpour; N Baradaran Rafiee; S Ghaffari; A Jamal
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

10.  Simplified protocol of nuchal translucency measurement: Is it still effective?

Authors:  Sun Min Kim; Jong Kwan Jun
Journal:  Obstet Gynecol Sci       Date:  2013-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.